Scientific Council Member
Robert H. Lenox, M.D.
Robert H. Lenox, M.D.
Professor of Pharmacology and Clinical Neurosciences
1995, 2001 Distinguished Investigator Grantee
Dr. Lenox’s research has focused on identifying the molecular events in the brain mediating neuroplastic changes targeted by chronic lithium treatment of bipolar disorder. His lab’s studies led to the discovery of sites in the promoter region of a phosphoprotein that may be integral to signaling-dependent cytoskeletal changes in the brain. These sites play a role in the pathophysiology of bipolar disorder and neurobiology of mood regulation.
While Vice President and Worldwide Head of Central Nervous System (CNS) Drug Discovery for Sanofi Pharmaceuticals, Dr. Lenox set strategy and led program progression to clinical development for psychiatry and neurology. Prior to entering the pharmaceutical industry in 2001, he held an endowed faculty position and was Vice Chair for Research Development in the Department of Psychiatry at the University of Pennsylvania School of Medicine. Dr. Lenox currently provides consultation for CNS drug discovery and development within academic, biotech and pharmaceutical settings.
Learn More About the Foundation
The Brain & Behavior Research Foundation is a global nonprofit organization focused on improving the understanding, prevention and treatment of psychiatric and mental illnesses.
Beginning in 1987, the Brain & Behavior Research Foundation was providing seed money to neuroscientists to invest in “out of the box” research that the government and other sources were unwilling to fund. Today, Brain & Behavior Research Foundation is still the leading, private philanthropy in the world in this space.
Meet the people who make up the Brain & Behavior Research Foundation. Our staff of experts, passionate Board of Directors, and Scientific Council which includes Nobel prize winners and chairs of psychiatric departments around the world.
We take our responsibility to our donors seriously and believe that our financial operations must be transparent. We're proud to say that 100% of your contribution for research is invested directly in research grants.